Home > Insider Trading > Filing (0001289340-12-000038)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1289340	Stereotaxis Inc.	STXS	Electromedical & Electrotherapeutic Apparatus (3845)	943120386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267959	A Fred Middleton	400 South El Camino Real Suite 1200 San Mateo CA 94402-1708		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-05-10	6,241,119	$0.00	7,822,726	No	4	P	Indirect	Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock	Acquisiton	2012-05-10	265,062	$0.00	281,178	No	4	P	Indirect	Sanderling Ventures Management VI

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Sanderling Venture Partners VI Co-Investment Fund, L.P.
No	4	P	Indirect	Sanderling Ventures Management VI

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2012-05-10	6,241,119	$0.00	6,241,119	$0.34
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2012-05-10	265,062	$0.00	265,062	$0.34
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2012-05-07	1,498,482	$0.00	1,498,482	$0.34
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2012-05-07	29,000	$0.00	29,000	$0.34
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2012-05-07	34,553	$0.00	34,553	$0.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,241,119	2012-05-10	2018-05-10	No	4	P	Indirect
265,062	2012-05-10	2018-05-10	No	4	P	Indirect
1,498,482	2012-05-07	2017-05-07	No	4	J	Indirect
29,000	2012-05-07	2017-05-07	No	4	J	Indirect
34,553	2012-05-07	2017-05-07	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	340,932	Direct
Common Stock	30,609	Indirect	Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock	36,470	Indirect	Sanderling VI Limited Partnership
Common Stock	781,351	Indirect	Sanderling Venture Partners II, L.P.
Common Stock	15,000	Indirect	Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock	532,758	Indirect	Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock	110,971	Indirect	Sanderling V Beteiligungs GmbH & Co. KG
Common Stock	397,164	Indirect	Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock	119,566	Indirect	Sanderling V Limited Partnership
Common Stock	677,906	Indirect	Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock	224,515	Indirect	Sanderling Venture Partners iV Co-Investment Fund
Common Stock	828	Indirect	Sanderling Ventures Management V
Common Stock	797	Indirect	Middleton McNeil Retirement Trust

Footnotes

The reported securities are included within 6,241,119 Stereotaxis units purchased by the reporting person for 0.4611 per unit. Each unit consists of one share of common stock, and one warrant to purchase one share of common stock.
The reported securities are included within 265,062 Stereotaxis units purchased by the reporting person for 0.4611 per unit. Each unit consists of one share of common stock, and one warrant to purchase one share of common stock.
The warrant was issued dated May 7, 2012, subject to closing conditions, which were satisfied on May 11, 2012. Beneficial ownership was acquired on May 11, 2012, upon satisfaction of closing conditions.
Warrant received in connection with the extension of an unsecured loan commitment between Sanderling Venture Partners VI Co-Investment Fund, L.P., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, respectively, and Issuer.